October 22, 2012
SAN DIEGO, Oct. 22, 2012 (GLOBE NEWSWIRE) -- Somaxon
Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty
pharmaceutical company, today announced that it will release
its financial results for the third quarter ended September
30,
2012 on Wednesday, October 31, 2012 after the close of the
U.S. financial markets. The Company will also conduct a
conference call that same afternoon at 4:30 p.m. ET (1:30
p.m. PT) to discuss results and highlights of the third
quarter of
2012.
The conference call will be available to interested parties
through a live audio webcast at
http://investors.somaxon.com/events.cfm. The webcast will
also be archived and accessible at this site for one year.
Alternatively, callers may participate in the live conference
call by dialing (877) 941-9205 (domestic) or (480) 629-9771
(international), conference call ID 4570871. A telephonic
replay will be available for approximately two weeks
following the conclusion of the call by dialing (303)
590-3030, and entering passcode 4570871.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc.
is a specialty pharmaceutical company focused on the in-
licensing, development and commercialization of proprietary
branded products and late-stage product candidates to treat
important medical conditions where there is an unmet medical
need and/or high-level of patient dissatisfaction, currently
in the central nervous system therapeutic area.
Somaxon's product Silenor, now available by prescription
in the United States, is indicated for the treatment of
insomnia characterized by difficulty with sleep
maintenance.
The Somaxon Pharmaceuticals logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13679
For more information, please visit the company's web
site at www.somaxon.com.
CONTACT: Tran Nguyen / CFO
Somaxon Pharmaceuticals, Inc. (858) 876-6500
Matt Sheldon PondelWilkinson Inc. (310) 279-5975
Source: Somaxon Pharmaceuticals, Inc. News Provided by
Acquire Media
distributed by |